Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial
-
Published:2024-07
Issue:
Volume:154
Page:106868
-
ISSN:1368-8375
-
Container-title:Oral Oncology
-
language:en
-
Short-container-title:Oral Oncology
Author:
Imamura YoshinoriORCID,
Kiyota NaomiORCID,
Tahara Makoto,
Kodaira Takeshi,
Hayashi Ryuichi,
Nishino Hiroshi,
Asada Yukinori,
Mitani Hiroki,
Iwae Shigemichi,
Nishio Naoki,
Onozawa Yusuke,
Hanai Nobuhiro,
Ohkoshi Akira,
Hara Hiroki,
Monden Nobuya,
Nagaoka Masato,
Minami Shujiro,
Kitabayashi Ryo,
Sasaki Keita,
Homma Akihiro
Reference45 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden;Hashim;Ann Oncol,2019
3. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Machiels;Ann Oncol,2020
4. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009
5. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献